[ad_1] Pleased to co-edit this summer’s #genetherapy issue of International Ophthalmology Clinics: https://t.co/SQ6puXq6fb “DNA- and RNA-based Gene Therapies in Ophthalmology: Preclinical, Clinical and Commercial Considerations” #eye #retina #gene #Biotechnology Fig: Church Wiki Commons https://t.co/LeeyWkSUDI [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Pleased to co-edit this summer’s #genetherapy issue of International Ophthalmology Clinics: https://t.co/SQ6puXq6fb “DNA- and RNA-based Gene Therapies in Ophthalmology: Preclinical, Clinical and Commercial Considerations” #eye #retina #gene #clinicalresearch #biotechnology [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
#eyes #retina #macula #GeneTherapy #AMD #diabeticretinopathy #suprachoroidal https://t.co/VDeaX0uDZS
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Vertical Transect Analysis of Optical Coherence Tomography Images in Patients Treated for Diabetic Macular Edema | IOVS | ARVO Journals https://t.co/cBg6MpN5wa #eyes #retina #macula #diabeticretinopathy https://t.co/bBWpIFRgPo [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Suprachoroidal Injections Across Species Analyzed via Multimodal Imaging | IOVS | ARVO Journals https://t.co/3VL75CQ1A0 #eye #retina #suprachoroidal #drugdelivery https://t.co/feGhLzkEbx [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Just published:”The proposed mathematical model suggests that changes in #retinal and choroidal oxygen supplies impact the oxygenation of the macular tissue differentially. These results may help better understand the pathogenesis of #maculardegeneration.” https://t.co/ug2kux4fgC
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] OIS Podcast Episode #270: KOLs Speak Out on the Future of Gene Therapy https://t.co/nXMnR91Btg via @YouTube [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @ModernRetina: @BauschLomb and Clearside Biomedical Inc. announced that the U.S. Food and Drug Administration (@US_FDA) has accepted the… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Just published…Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in Rabbits | TVST | ARVO Journals https://t.co/py84aPE3Ra
#retina #AMD #maculardegeneration #suprachoroidal #cls-ax
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Just published: https://t.co/WYQcf8TY9n “Suprachoroidal delivery of axitinib, combined with pan-VEGF inhibition activity of axitinib, has the potential to provide additional benefits compared to the current standard of care with intravitreal anti–VEGF-A agents.” #retina #AMD [ad_2] Source by Thomas Ciulla, MD, MBA Return to main …